OXICARDIUM

Our advanced formula has been developed with the goal of effectively regulating blood cholesterol levels. The hypocholesterolemic activity of the product was measured through its action on the substrate of HMG-CoA reductase, a key enzyme in the transformation of mevalonate, resulting in a reduction of endogenous cholesterol synthesis. In addition to this mechanism, there is also a direct action on hepatic LDL reabsorption, leading to the elimination of free cholesterol through its binding with bile.